Rumors on the Toronto board that there is a buyout offer on the table. Crazy speculation of $14.00 a share. If it is true, could be something like $5 or 6 dollars. But that would elicit counteroffers for sure. Hope the rumors are true and we are not halted because of the remote possibility of some adverse event in one of the clinical trials.